Word

Status

Pending

Status Code

641

Status Date

Thursday, August 15, 2024

Serial Number

79392431

Mark Type

2

Filing Date

Monday, January 15, 2024

Trademark Owner History

Barinthus Biotherapeutics (UK) Limited

Classifications

5 Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceuticals for the treatment and/or prevention of cancer, infectious diseases, and immune and autoimmune diseases; pharmaceutical preparations for the treatment and/or prevention of cancer, infectious diseases, and immune and autoimmune diseases; pharmaceutical products for the treatment and/or prevention of cancer, infectious diseases, and immune and autoimmune diseases; pharmaceuticals, pharmaceutical preparations and pharmaceutical products for the induction of immune tolerance; immunotherapeutics; immunotherapeutics for the treatment and/or prevention of cancer and infectious diseases, and immune and autoimmune diseases; vaccines; viral vaccines; vaccines for the treatment and/or prevention of influenza and other infectious diseases; vaccines for the treatment and/or prevention of cancer; viral antigens

Trademark Events

Mar 28, 2024

Sn Assigned For Sect 66a Appl From Ib

Aug 2, 2024

Assigned To Examiner

Apr 1, 2024

New Application Office Supplied Data Entered

Apr 5, 2024

Application Filing Receipt Mailed

Aug 5, 2024

Non-Final Action Written

Aug 6, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Aug 15, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Aug 15, 2024

Refusal Processed By Mpu

Sep 1, 2024

Refusal Processed By Ib